Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

This Week's Healthcare Earnings: Novo, Elevance And More No Photo Available

Yeji Jesse Lee

More than half a dozen healthcare companies posted earnings this week, including big names like Pfizer, Elevance and Roche. Here's wha... (more story)

4 Things To Know As DOL Pitches Transparency For PBMs No Photo Available

Kellie Mejdrich

The U.S. Department of Labor's proposal to require pharmacy benefit managers to give employer-provided health plans detailed informati... (more story)

Seeking Rural Health Funds, States Mull Limiting Their Powers No Photo Available

Mark Payne

A $50 billion federal fund for rural healthcare providers is prompting some policymakers to rethink laws requiring medical facilities ... (more story)